Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Silybin × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Thoracic 1 Genitourinary 1 Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Trastuzumab 622 Paclitaxel 584 Cyclophosphamide 553 Docetaxel 489 Capecitabine 433 Letrozole 370 Fulvestrant 334 Carboplatin 330 Doxorubicin 293 Tamoxifen 265 Anastrozole 232 pembrolizumab 230 Radiotherapy 216 exemestane 215 Epirubicin 208 pertuzumab 190 Bevacizumab 190 palbociclib 180 Gemcitabine 179 Vinorelbine 172 Lapatinib 164 Magnetic Resonance Spectroscopy 149 130-nm albumin-bound paclitaxel 145 eribulin 135 Albumin-Bound Paclitaxel 133 Surveys and Questionnaires 131 Exercise 128 Fluorouracil 114 Drug Therapy 112 Taxes 111

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05689619 2023-12-15

SILMET

A.O.U. Città della Salute e della Scienza

Phase NA Recruiting

BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡